Conference Coverage

SGLT-2 inhibitors promising for heart failure prevention, not treatment

Publish date: January 12, 2019

 

EXPERT ANALYSIS FROM WCIRDC 2018

Pages

Recommended Reading

Should metabolic syndrome be renamed circadian syndrome?
Journal of Clinical Outcomes Management
Study investigates statin-diabetes link
Journal of Clinical Outcomes Management
New diabetes guidelines downgrade insulin as first-line injectable treatment
Journal of Clinical Outcomes Management
Active migraine in women linked to lower risk of developing T2DM
Journal of Clinical Outcomes Management
New risk-prediction model for diabetes under development
Journal of Clinical Outcomes Management
‘Payoff will be great’ if we can conquer childhood obesity, expert says
Journal of Clinical Outcomes Management
New diabetes drugs solidify their cardiovascular and renal benefits
Journal of Clinical Outcomes Management
Researchers exploring ways to mitigate aging’s impact on diabetes
Journal of Clinical Outcomes Management
Torrent Pharmaceuticals expands losartan recall
Journal of Clinical Outcomes Management
Does reduced degradation of insulin by the liver cause type 2 diabetes?
Journal of Clinical Outcomes Management